This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is It Worth Investing in Exxon (XOM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Exxon (XOM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
XOMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Marathon Petroleum (MPC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Marathon Petroleum (MPC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MPCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Advanced Micro (AMD): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Advanced Micro (AMD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AMDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
United Therapeutics (UTHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
UTHRPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Eldorado Gold (EGO)
by Zacks Equity Research
Eldorado Gold (EGO) possesses solid growth attributes, which could help it handily outperform the market.
EGOPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Vertiv (VRT)
by Zacks Equity Research
Vertiv (VRT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
VRTPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why AvalonBay (AVB) Is a Great Growth Stock
by Zacks Equity Research
AvalonBay (AVB) possesses solid growth attributes, which could help it handily outperform the market.
AVBPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Equity Lifestyle Properties (ELS) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Equity Lifestyle Properties (ELS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ELSPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Wall Street Bulls Look Optimistic About Vertiv (VRT): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vertiv (VRT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VRTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Boeing (BA) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Boeing (BA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
BAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Novavax (NVAX): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Novavax (NVAX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
NVAXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Cava (CAVA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Cava (CAVA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CAVAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Spotify (SPOT) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Spotify (SPOT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SPOTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Netflix (NFLX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Netflix (NFLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NFLXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Royal Caribbean (RCL) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Royal Caribbean (RCL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
RCLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Skechers (SKX) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Skechers (SKX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SKXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chewy (CHWY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Chewy (CHWY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CHWYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in JPMorgan Chase & Co. (JPM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), JPMorgan Chase & Co. (JPM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
JPMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Why Growth Investors Shouldn't Overlook Texas Roadhouse (TXRH)
by Zacks Equity Research
Texas Roadhouse (TXRH) possesses solid growth attributes, which could help it handily outperform the market.
TXRHPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Avery Dennison (AVY) Now
by Zacks Equity Research
Avery Dennison (AVY) could produce exceptional returns because of its solid growth attributes.
AVYPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Brinker International (EAT) Now
by Zacks Equity Research
Brinker International (EAT) could produce exceptional returns because of its solid growth attributes.
EATPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Micron (MU) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Micron (MU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Schlumberger (SLB) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Schlumberger (SLB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SLBPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Accenture (ACN) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Accenture (ACN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ACNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Zscaler (ZS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Zscaler (ZS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ZSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth